| 101 |
SHIRE LLC et al v. MYLAN PHARMACEUTICALS, INC. et al |
2:12-cv-00638 |
D.N.J. |
|
|
|
|
| 102 |
SHIRE LLC et al v. MYLAN PHARMACEUTICALS, INC. et al |
2:12-cv-00638 |
D.N.J. |
|
|
|
|
| 103 |
SHIRE LLC et al v. MYLAN PHARMACEUTICALS, INC. et al |
2:12-cv-00638 |
D.N.J. |
|
|
|
|
| 104 |
SHIRE LLC et al v. MYLAN PHARMACEUTICALS, INC. et al |
2:12-cv-00638 |
D.N.J. |
|
|
|
|
| 105 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED et al v. MYLAN, INC. et al |
2:12-cv-00026 |
W.D.Pa. |
|
|
|
|
| 106 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED et al v. MYLAN, INC. et al |
2:12-cv-00026 |
W.D.Pa. |
|
|
|
|
| 107 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED et al v. MYLAN, INC. et al |
2:12-cv-00026 |
W.D.Pa. |
|
|
|
|
| 108 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED et al v. MYLAN, INC. et al |
2:12-cv-00026 |
W.D.Pa. |
|
|
|
|
| 109 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED et al v. MYLAN, INC. et al |
2:12-cv-00026 |
W.D.Pa. |
|
|
|
|
| 110 |
ABBOTT LABORATORIES et al v. MYLAN PHARMACEUTICALS INC. et al |
2:11-cv-04966 |
D.N.J. |
|
|
|
|
| 111 |
ABBOTT LABORATORIES et al v. MYLAN PHARMACEUTICALS INC. et al |
2:11-cv-04966 |
D.N.J. |
|
|
|
|
| 112 |
OREXO AB v. MYLAN PHARMACEUTICALS INC. et al |
3:11-cv-03788 |
D.N.J. |
|
|
|
|
| 113 |
DTECH Communications, LLC v. OSC Engineering, Inc. et al |
3:11-cv-01425 |
S.D.Cal. |
|
|
|
|
| 114 |
DTECH Communications, LLC v. OSC Engineering, Inc. et al |
3:11-cv-01425 |
S.D.Cal. |
|
|
|
|
| 115 |
WARNER CHILCOTT COMPANY, LLC v. MYLAN, INC. et al |
3:11-cv-03262 |
D.N.J. |
|
|
|
|
| 116 |
Bayer Schering Pharma AG et al v. Mylan Pharmaceuticals Inc. et al |
2:11-cv-00604 |
D.Nev. |
|
|
|
|
| 117 |
Bayer Schering Pharma AG et al v. Mylan Pharmaceuticals Inc. et al |
2:11-cv-00604 |
D.Nev. |
|
|
|
|
| 118 |
Pfizer Inc. v. Mylan Pharmaceuticals Inc. et al |
1:11-cv-00269 |
D.Del. |
|
|
|
|
| 119 |
Endo Pharmaceuticals Inc. v. Mylan Technologies Inc. et al |
1:11-cv-00220 |
D.Del. |
|
|
|
|
| 120 |
Vivelle Ventures LLC et al v. Mylan Technologies, Inc. et al |
1:11-cv-01187 |
S.D.N.Y. |
|
|
|
|
| 121 |
Vivelle Ventures LLC et al v. Mylan Technologies, Inc. et al |
1:11-cv-01187 |
S.D.N.Y. |
|
|
|
|
| 122 |
Vivelle Ventures LLC et al v. Mylan Technologies, Inc. et al |
1:11-cv-01187 |
S.D.N.Y. |
|
|
|
|
| 123 |
Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc. et al |
1:11-cv-00015 |
N.D.W.Va. |
|
|
|
|
| 124 |
Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc. et al |
1:11-cv-00015 |
N.D.W.Va. |
|
|
|
|
| 125 |
Somaxon Pharmaceuticals Inc. et al v. Actavis Elizabeth LLC et al |
1:10-cv-01100 |
D.Del. |
|
|
|
|
| 126 |
Somaxon Pharmaceuticals Inc. et al v. Actavis Elizabeth LLC et al |
1:10-cv-01100 |
D.Del. |
|
|
|
|
| 127 |
Astrazeneca Pharmaceuticals LP et al v. Mylan Pharmaceuticals Inc. et al |
1:10-cv-00199 |
N.D.W.Va. |
|
|
|
|
| 128 |
Astrazeneca Pharmaceuticals LP et al v. Mylan Pharmaceuticals Inc. et al |
1:10-cv-00199 |
N.D.W.Va. |
|
|
|
|
| 129 |
Abbott Laboratories et al v. Mylan Inc. et al |
1:10-cv-00559 |
D.Del. |
|
|
|
|
| 130 |
Abbott Laboratories et al v. Mylan Inc. et al |
1:10-cv-00559 |
D.Del. |
|
|
|
|
| 131 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
| 132 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
| 133 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
| 134 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
| 135 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
| 136 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
| 137 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
| 138 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:09-cv-00441 |
D.Del. |
|
|
|
|
| 139 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:09-cv-00441 |
D.Del. |
|
|
|
|
| 140 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:09-cv-00441 |
D.Del. |
|
|
|
|
| 141 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:09-cv-00441 |
D.Del. |
|
|
|
|
| 142 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. MYLAN PHARMACEUTICALS INC. et al |
2:09-cv-02073 |
D.N.J. |
|
|
|
|
| 143 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. MYLAN PHARMACEUTICALS INC. et al |
2:09-cv-02073 |
D.N.J. |
|
|
|
|
| 144 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. MYLAN PHARMACEUTICALS INC. et al |
2:09-cv-02073 |
D.N.J. |
|
|
|
|
| 145 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. MYLAN PHARMACEUTICALS INC. et al |
2:09-cv-02073 |
D.N.J. |
|
|
|
|
| 146 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. IMPAX LABORATORIES, INC. et al |
2:08-cv-06304 |
D.N.J. |
|
|
|
|
| 147 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. IMPAX LABORATORIES, INC. et al |
2:08-cv-06304 |
D.N.J. |
|
|
|
|
| 148 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. IMPAX LABORATORIES, INC. et al |
2:08-cv-06304 |
D.N.J. |
|
|
|
|
| 149 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. IMPAX LABORATORIES, INC. et al |
2:08-cv-06304 |
D.N.J. |
|
|
|
|
| 150 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. IMPAX LABORATORIES, INC. et al |
2:08-cv-06304 |
D.N.J. |
|
|
|
|